229 related articles for article (PubMed ID: 8275903)
1. [Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].
Leboyer M; Bouvard MP; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M
Encephale; 1993; 19(2):95-102. PubMed ID: 8275903
[TBL] [Abstract][Full Text] [Related]
2. [Psychopharmacology of autism].
Chabrol H; Bonnet D; Roge B
Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
[TBL] [Abstract][Full Text] [Related]
3. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
[TBL] [Abstract][Full Text] [Related]
4. [Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy].
Lensing P; Klingler D; Panksepp J; Huber M; Saria A; Hackenberg B; Adam H
Z Kinder Jugendpsychiatr; 1992 Sep; 20(3):185-96. PubMed ID: 1329399
[No Abstract] [Full Text] [Related]
5. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
Lensing P; Klingler D; Lampl C; Leboyer M; Bouvard M; Plumet MH; Panksepp J
Acta Paedopsychiatr; 1992; 55(3):169-73. PubMed ID: 1414352
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
Kolmen BK; Feldman HM; Handen BL; Janosky JE
J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):223-31. PubMed ID: 7896655
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone in autistic children: a double-blind and placebo-controlled study.
Campbell M; Anderson LT; Small AM; Locascio JJ; Lynch NS; Choroco MC
Psychopharmacol Bull; 1990; 26(1):130-5. PubMed ID: 2196621
[TBL] [Abstract][Full Text] [Related]
9. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.
Scifo R; Cioni M; Nicolosi A; Batticane N; Tirolo C; Testa N; Quattropani MC; Morale MC; Gallo F; Marchetti B
Ann Ist Super Sanita; 1996; 32(3):351-9. PubMed ID: 9028057
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of naltrexone on autistic behavior.
Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone in autistic children: behavioral symptoms and attentional learning.
Campbell M; Anderson LT; Small AM; Adams P; Gonzalez NM; Ernst M
J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1283-91. PubMed ID: 8282676
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone and communication skills in young children with autism.
Feldman HM; Kolmen BK; Gonzaga AM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):587-93. PubMed ID: 10230191
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
[TBL] [Abstract][Full Text] [Related]
15. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
[TBL] [Abstract][Full Text] [Related]
16. Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
Benjamin S; Seek A; Tresise L; Price E; Gagnon M
J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):238-42. PubMed ID: 7896657
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone in young autistic children: replication study and learning measures.
Kolmen BK; Feldman HM; Handen BL; Janosky JE
J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1570-8. PubMed ID: 9394942
[TBL] [Abstract][Full Text] [Related]
18. An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.
Sandman CA; Barron JL; Colman H
Am J Ment Retard; 1990 Jul; 95(1):93-102. PubMed ID: 2167107
[TBL] [Abstract][Full Text] [Related]
19. The effects of naltrexone in autistic children: report of two cases.
Akkök F
Turk J Pediatr; 1995; 37(1):19-23. PubMed ID: 7732604
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone plasma levels, clinical response and effect on weight in autistic children.
Gonzalez NM; Campbell M; Small AM; Shay J; Bluhm LD; Adams PB; Foltz RL
Psychopharmacol Bull; 1994; 30(2):203-8. PubMed ID: 7831456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
